Skip to main content

Advertisement

Log in

Discrepancy between clinical and pathological diagnoses of CBD and PSP

  • ORIGINAL CONTRIBUTION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are often clinically confused with each other. Moreover, the discrepancy between clinical and pathological diagnoses of CBD and PSP are still controversial. We report here two atypical cases of PSP and CBD. A 73–yearold woman was admitted with right hand rigidity, limb kinetic apraxia and cortical sensory loss. Brain atrophy, hypoperfusion and hypometabolism predominantly in the left frontoparietal lobes indicated CBD clinically. Pathological studies revealed neuronal loss and spongy change without ballooned neurons (BN) in the cerebral cortex. Modified Gallyas–Braak (G–B) staining revealed neurofibrillary tangles (NFTs) and tufted astrocytes, indicating pathological diagnosis of PSP. A 75–year–old man admitted with vertical gaze palsy, neck dystonia, parkinsonism and dementia. Atrophy of the frontal lobes and tegmentum of the midbrain and symmetrical frontal hypoperfusion in SPECT indicated PSP. However, neuronal loss and BN in the frontal lobes and clusters of astrocytic plaques indicated CBD pathologically. The G–B staining was useful for differentiating between CBD and PSP, but our atypical cases bring up a new issue about differential diagnosis of CBD and PSP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arai T, Ikeda K, Akiyama H, Nonaka T, Hasegawa M, Ishiguro K, Iritani S, Tsuchiya K, Iseki E, Yagishita S, Oda T, Mochizuki A (2004) Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 55:72–79

    Article  CAS  PubMed  Google Scholar 

  2. Arai T, Ikeda K, Akiyama H, Shikamoto Y, Tsuchiya K, Yagishita S, Beach T, Rogers J, Schwab C, McGeer PL (2001) Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick’s disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 101:167–173

    CAS  PubMed  Google Scholar 

  3. Bergeron C, Pollanen MS, Weyer L, Black SE, Lang AE (1996) Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 40:893–900

    Article  CAS  PubMed  Google Scholar 

  4. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I (2002) Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946

    CAS  PubMed  Google Scholar 

  5. Gibb WR, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112(Pt 5):1171–1192

    PubMed  Google Scholar 

  6. Hattori M, Yoshida M, Ojika K, Yuasa H, Mitake S, Hashizume Y (2000) An autopsy case of corticobasal degeneration without prominent cortical pathology – an imitator of progressive supranuclear palsy. Rinsho Shinkeigaku 40:372–377

    CAS  PubMed  Google Scholar 

  7. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015–2019

    CAS  PubMed  Google Scholar 

  8. Hauw JJ, Verny M, Delaere P, Cervera P, He Y, Duyckaerts C (1990) Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer’s disease and aging. Neurosci Lett 119: 182–186

    Article  CAS  PubMed  Google Scholar 

  9. Hof PR, Delacourte A, Bouras C (1992) Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (Berl) 84:45–51

    Article  CAS  PubMed  Google Scholar 

  10. Ikebe S, Mori H, Sumino S, Takanashi M, Hamano Y, Shirai T, Ohkuma Y, Mizuno Y (2000) A 77-year-old man with gait and gaze disturbance. No To Shinkei 52:269–279

    CAS  PubMed  Google Scholar 

  11. Inagaki T, Seno HI, Iijima M, Nagai A, Bokura H, Kobayashi S, Wada M, Harada T (1998) A case manifested overlapping neuropathologic features of both progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). No To Shinkei 50:263–271

    CAS  PubMed  Google Scholar 

  12. Katsuse O, Iseki E, Arai T, Akiyama H, Togo T, Uchikado H, Kato M, de Silva R, Lees A, Kosaka K (2003) 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 106:251–260

    Article  PubMed  Google Scholar 

  13. Komori T, Arai N, Oda M, Nakayama H, Mori H, Yagishita S, Takahashi T, Amano N, Murayama S, Murakami S, Shibata N, Kobayashi M, Sasaki S, Iwata M (1998) Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 96:401–408

    CAS  PubMed  Google Scholar 

  14. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele- Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9

    CAS  PubMed  Google Scholar 

  15. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RK, Bartko JJ (1997) Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 48: 119–125

    CAS  PubMed  Google Scholar 

  16. Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, Verny M, Jellinger K, Chaudhuri KR, Pearce RK (1999) Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(Suppl 2):II1–II5

    PubMed  Google Scholar 

  17. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97–105

    CAS  PubMed  Google Scholar 

  18. Mori H, Nishimura M, Namba Y, Oda M (1994) Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol (Berl) 88:113–121

    Google Scholar 

  19. Paulus W, Selim M (1990) Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol (Berl) 81:89–94

    Article  CAS  PubMed  Google Scholar 

  20. Rebeiz JJ, Kolodny EH, Richardson EP Jr (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18:20–33

    CAS  PubMed  Google Scholar 

  21. Riley DE, Lang AE, Lewis A, Resch L, Ashby P, Hornykiewicz O, Black S (1990) Cortical-basal ganglionic degeneration. Neurology 40:1203–1212

    CAS  PubMed  Google Scholar 

  22. Rinne JO, Lee MS, Thompson PD, Marsden CD (1994) Corticobasal degeneration. A clinical study of 36 cases. Brain 117(Pt 5):1183–1196

    PubMed  Google Scholar 

  23. Sako H, Nakamura H, Inoue K, Takada K, Tanaka J, Tabuchi Y (1986) Progressive supranuclear palsy – A case with a marked frontal atrophy. Neuropathol 7:7–14

    Google Scholar 

  24. Scully RE, Mark EJ, McNeely WF, McNeely BU (1993) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 46 – 1993. N Engl J Med 329:1560–1567

    Article  PubMed  Google Scholar 

  25. Shiozawa M, Fukutani Y, Sasaki K, Isaki K, Hamano T, Hirayama M, Imamura K, Mukai M, Arai N, Cairns NJ (2000) Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy. Clin Neuropathol 19:192–199

    CAS  PubMed  Google Scholar 

  26. Steele JC, Richardson JC, Olszewski J (1964) Progressive Supranuclear Palsy. A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum with Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia. Arch Neurol 10:333–359

    CAS  PubMed  Google Scholar 

  27. Wakabayashi K, Oyanagi K, Makifuchi T, Ikuta F, Homma A, Homma Y, Horikawa Y, Tokiguchi S (1994) Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol (Berl) 87:545–553

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Mizuno.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mizuno, ., Shiga, K., Nakata, . et al. Discrepancy between clinical and pathological diagnoses of CBD and PSP. J Neurol 252, 687–697 (2005). https://doi.org/10.1007/s00415-005-0718-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0718-y

Key words

Navigation